DIACARTA

History

Year	Detail
2011	Aiguo Zhang and Paul Okunieff founded DiaCarta.
2023	The company received FDA approval for its Over The Counter (OTC) home iColon Fecal Occult Blood Test (FOBT).
2024	DiaCarta Inc. and OncoAssure Ltd. collaborated to launch the Prostate Cancer Lab Developed Test.

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.